X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

Astellas Partners with CNBC for its Global Branding Campaign

Yuvraj_pawp by Yuvraj_pawp
30th October 2017
in Americas, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Astellas Pharma Inc. announced the next installment of its global corporate branding initiative, which it is conducting in collaboration with CNBC, the world’s number one business and financial news network. The integrated campaign launches on November 1 and will run on CNBC’s platforms in the United States, EMEA and Asia.

Astellas initiated its global corporate branding program in 2015 to raise visibility of the company globally and reinforce its corporate VISION and values. The company’s branding activities focus on highlighting Astellas employees and innovation on television and digital media.

The new campaign will enable Astellas to share its VISION of turning innovative science into value for patients on CNBC channels globally via a 30-second television advertisement. The advertisement introduces the new campaign slogan, “with Meaningful Science,” which demonstrates the company’s patient-focused approach.It illustrates the teamwork of Astellas employees, who are depicted as a group of cellists playing together in perfect harmony symbolizing the company’s approach to innovative collaboration. The performers are joined by a crowd of spectators captivated by the music which reflect Astellas’ pursuit of creating meaningful value for patients.

The TV commercial launch is timed to coincide with this year’s TEDMED event, where Astellas will hold a discussion over breakfast in conjunction with CNBC Catalyst, the network’s in-house commercial agency. The session will explore the future of cancer care and support. 

Please refer to the attached reference materials for the details of the commercial and the campaign.

About CNBC
CNBC is the number one business and financial news network on the planet. Our mission is to help the influential and aspirational make astute decisions to get ahead. CNBC International ensures no matter where you are you can keep up to date with the latest breaking business and financial news. With global headquarters in the US and international headquarters in London and Singapore, we provide the perfect 24-hour global business briefing. In addition to our global TV channel, available in more than 409 million homes worldwide, CNBC is also available on mobile, tablet and desktop. CNBC.com is the preeminent financial news source on the web, featuring an unprecedented amount of video, real-time market analysis, web-exclusive live video and analytical financial tools.

About TEDMED
TEDMED is the independent health and medicine edition of the world-famous TED conference, dedicated to “ideas worth spreading.” TED Talks have been viewed online over two billion times around the world. TEDMED is a non-profit that is wholly owned by The TEDMED Foundation, a 501(c)(3) Public Charity.

TEDMED bridges the gap between science and the public by finding and sharing stories that inform, inspire, engage and provoke action across a broad, passionate community both inside and outside of health and medicine. TEDMED values inclusiveness, multi-disciplinary collaboration and diversity in its mission to catalyze a healthier world.

About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at https://www.astellas.com/en

Tags: America
Previous Post

Enterome completes first phase 1 study of EB8018 to treat Crohn’s disease

Next Post

Eisai To Present Latest Data At 10th Clinical Trials On Alzheimer’s Diesase

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In